Intelligent Bio Solutions Inc
GBS
Market Cap$433.58K
Close$
Share Statistics
| Market cap | $433,577.00 |
|---|---|
| Enterprise Value | $416,328.00 |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-6.1 |
| Beta | 0 |
| Outstanding Shares | 5,771,911 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -0.3 |
|---|---|
| PEG | -1.05 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.11 |
| Enterprise Value to EBIT | -0.04 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 6.7 |
| Debt to Equity | 0.55 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About GBS Inc
8 employeesGBS Inc. is on a mission to put the power of non-invasive, real-time diagnostic testing in the hands of patients and their primary health practitioners at point of care. With the world-first Biosensor Platform, GBS Inc. is developing and...